Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
14.42
-0.68 (-4.50%)
Aug 21, 2026, 3:04 PM CST

SHE:002393 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,3021,3921,3361,1531,1471,092
Revenue Growth
-1.58%4.18%15.88%0.56%5.00%-4.29%
Gross Profit
671.68747.08712.11665.06636.08618
Operating Income
114.4393.4669.41118.661.0528.66
Net Income
151.69416.28184.53361.8393.61122.11
Earnings Per Share
0.491.350.601.170.300.40
EPS Growth
-64.55%125.00%-48.57%284.29%-23.87%1238.26%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northern China
579.59497.76552.77496.66446.15
Northeast China
53.8861.1720.1725.0725.57
East China
322.92307.6224.86270.81241.41
South Central China
228.87280.25202.74160.64187.33
Southwest China
119.22113.4390.83122.7126.51
North-West China
84.8573.5558.9166.9560.95
Export
2.682.382.753.754.02
Total
1,3921,3361,1531,1471,092

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,2972,5582,3692,2201,9941,652
Total Debt
12.9445.4951.0133.4245.0834.74
Net Cash (Debt)
2,2842,5132,3182,1871,9491,617
Net Cash Growth
9.30%8.39%6.01%12.23%20.49%4.86%
Net Cash Per Share
7.358.157.547.056.325.28

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
133.47247.588.26200.01331.38196.34
Capital Expenditures
-34.94-37.46-53.75-61.72-40.91-88.24
Free Cash Flow
98.53210.0434.51138.29290.47108.1
Free Cash Flow Growth
73.00%508.58%-75.04%-52.39%168.71%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
51.58%53.67%53.30%57.68%55.48%56.60%
Operating Margin
8.79%6.71%5.20%10.29%5.32%2.62%
Pretax Margin
11.46%32.73%16.16%36.44%10.32%12.56%
Profit Margin
11.65%29.90%13.81%31.38%8.16%11.18%
FCF Margin
7.57%15.09%2.58%11.99%25.33%9.90%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.0000.7500.2920.3570.1790.179
Dividend Per Share Growth
191.43%157.11%-18.31%99.94%0%200.17%
Dividend Yield
6.81%4.32%2.11%2.51%1.56%1.56%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
30.9113.3624.4513.2941.8532.29
Forward PE
-18.1818.1818.1818.1818.18
P/FCF Ratio
47.2226.48130.7234.7813.4936.48
PS Ratio
3.574.003.384.173.423.61